Safety and efficacy
For a vaccine to reach the general public, it will have to work and be safe. Many potential vaccines for COVID-19 are being studied and tested. The testing and approvals process has been sped up by prompt funding and a reduction in paperwork. The length of the trials have not been shortened, and the usual safety measures remain in place.
Eligibility
It’s hoped small quantities of a vaccine could be available imminently and it will be prioritised to protect those who are most vulnerable to the impacts of COVID-19.
Health and social care workers, care home residents and staff have been prioritised to receive a vaccine first, with roll out to older people in age bands from next year.
The JCVI determines eligibility at a UK level. This is based on knowledge around clinical risk and effectiveness of the vaccine in different groups.
More information on definitions of workers/staff is expected from the JCVI along with recommendations based on vaccine trials data. Their current interim advice is here:
